News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Unmet needs in vaccine development July 10, 2025
    Nature Reviews Drug Discovery, Published online: 10 July 2025; doi:10.1038/d41573-025-00100-3Unmet needs in vaccine development
    Jennifer Heller
  • The US biosimilars market after one decade July 9, 2025
    Nature Reviews Drug Discovery, Published online: 09 July 2025; doi:10.1038/d41573-025-00101-2The US biosimilars market after one decade
    Kritika Chaudhari
  • Lilly buys Verve and its in vivo gene editors for up to US$1.3 billion July 9, 2025
    Nature Reviews Drug Discovery, Published online: 09 July 2025; doi:10.1038/d41573-025-00120-zLilly buys Verve and its in vivo gene editors for up to US$1.3 billion
    Asher Mullard
  • Dual-payload ADCs move into first oncology clinical trials July 8, 2025
    Nature Reviews Drug Discovery, Published online: 08 July 2025; doi:10.1038/d41573-025-00121-yTwo dual-payload antibody–drug conjugates are now in the clinic for cancer, with many more on the way.
    Asher Mullard
  • FDA approves twice-yearly capsid inhibitor for HIV prevention July 8, 2025
    Nature Reviews Drug Discovery, Published online: 08 July 2025; doi:10.1038/d41573-025-00117-8FDA approves twice-yearly capsid inhibitor for HIV prevention
    Asher Mullard
  • The changing landscape of medicinal chemistry optimization July 7, 2025
    Nature Reviews Drug Discovery, Published online: 07 July 2025; doi:10.1038/s41573-025-01225-1Medicinal chemistry optimizations in the progression from hit to lead to drug candidate affect properties of small-molecule drugs such as their molecular weight and lipophilicity. This Perspective analyses the properties of orally administered small-molecule drug candidates reported in the period 2015–2022 and their corresponding hit and […]
    Anita Rácz
  • Stealthy polymer attacks Gram-negative bacteria July 2, 2025
    Nature Reviews Drug Discovery, Published online: 02 July 2025; doi:10.1038/d41573-025-00118-7Stealthy polymer attacks Gram-negative bacteria
    Katie Kingwell
  • Targeting the Hippo pathway in cancer June 30, 2025
    Nature Reviews Drug Discovery, Published online: 30 June 2025; doi:10.1038/s41573-025-01234-0The Hippo signalling pathway fulfils a vital role in the regulation of tissue homeostasis and organ development and its dysregulation is associated with several diseases. This Review provides an overview of Hippo pathway signalling and regulation, highlighting its biological functions and role in diseases. Recent advances […]
    Kieran F. Harvey

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia™.

Attending on behalf of Vitreon America™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America™ was established with the goal of commercializing their Botanicopeia™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com